Charles A. Nicolette
Chief Executive Officer at CoImmune, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Edgardo Baracchini | M | 64 |
CoImmune, Inc.
 CoImmune, Inc. Pharmaceuticals: MajorHealth Technology CoImmune, Inc. engages in manufacture and development of cell-based therapeutics. It offers warehouse management, processing suites, logistics, research labs, and qualification and validation. The company was founded in February 2019 and is headquartered in Durham, NC. | 3 years |
| Gregory Tibbitts | M | 57 |
CoImmune, Inc.
CoImmune, Inc. Pharmaceuticals: MajorHealth Technology CoImmune, Inc. engages in manufacture and development of cell-based therapeutics. It offers warehouse management, processing suites, logistics, research labs, and qualification and validation. The company was founded in February 2019 and is headquartered in Durham, NC. | 3 years |
| Michael Fekete | M | 59 |
CoImmune, Inc.
CoImmune, Inc. Pharmaceuticals: MajorHealth Technology CoImmune, Inc. engages in manufacture and development of cell-based therapeutics. It offers warehouse management, processing suites, logistics, research labs, and qualification and validation. The company was founded in February 2019 and is headquartered in Durham, NC. | 3 years |
| Irina Y. Tcherepanova | M | - |
CoImmune, Inc.
CoImmune, Inc. Pharmaceuticals: MajorHealth Technology CoImmune, Inc. engages in manufacture and development of cell-based therapeutics. It offers warehouse management, processing suites, logistics, research labs, and qualification and validation. The company was founded in February 2019 and is headquartered in Durham, NC. | 5 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Lori R. Harrelson | F | 54 | - | |
| Andrei Vladimirovich Petrov | M | 50 | 3 years | |
| Philippe van Holle | M | 69 | 2 years | |
| Alexey Vinogradov | M | 54 | 2 years | |
| Robert Carey | M | 65 | 4 years | |
| Sander J. van Deventer | M | 69 | 17 years | |
| Clint G. Dederick | M | - | 4 years | |
| Louis J. Arcudi | M | 63 |
Genzyme Molecular Oncology
 Genzyme Molecular Oncology Pharmaceuticals: MajorHealth Technology Part of Sanofi, Genzyme Molecular Oncology is a company that develops novel cancer therapeutics and diagnostics. The company is based in Cambridge, MA. The company was founded by Gail J. Maderis. | 5 years |
| Richard D. Katz | M | 60 | 2 years | |
| Monique Laliberte | F | - | - | |
| Jean Lamarre | M | 70 | 2 years | |
| Brian Underdown | M | 83 | 17 years | |
| John N. Bonfiglio | M | 69 | 4 years | |
| John D. Menditto | M | - | 2 years | |
| David Gryska | M | 68 | 2 years | |
| Joan C. Winterbottom | F | 67 | 2 years | |
| Igor Krol | M | 51 | - | |
| Douglas C. Plessinger | M | 55 | - | |
| Irackly Mtibelishvily | M | - | 2 years | |
| Matthew Foster | M | - | - | |
| Michel Gréco | M | 80 | 8 years | |
| Lothar H. Finke | M | - | 5 years | |
| Gilbert W. Carnathan | M | - | - | |
| Tamao Watanabe | M | - | - | |
| Lee F. Allen | M | 72 | 1 years | |
| Frederick M. Miesowicz | M | 75 | 13 years | |
| Timothy Trost | M | 66 | 8 years | |
| Richard G. Morrison | M | 87 | - | |
| M. Douglas Winship | M | 75 | 1 years | |
| Ralph Snyderman | M | 84 | 1 years | |
| Shawn Leland | M | 40 | 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 35 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Charles A. Nicolette
- Personal Network
